Studies have demonstrated that KLF4 performs a tumor suppression function in gastrointestinal cancers [77, 78], T-cell acute lymphoblastic leukemia (T-ALL) [79], lung cancer [80], meningioma [81] and bladder cancer [82]. This evidence concerns the gene KLF4 and neoplasm.